Laura Romero-Gutiérrez

Laura Romero-Gutiérrez

Auto-generated profile, based on publicly available information

Laura Romero-Gutiérrez

Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Cuidados Intensivos. Ciudad de México, México

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2023 in Clinical and Translational Science
Verified
Journal Article
Open access
Ruth Madera-SandovalRuth Madera-Sandoval
Ruth Madera-Sandoval
ACArturo Cerbulo
Arturo Cerbulo
LALourdes Andrea Arriaga-Pizano
Lourdes Andrea Arriaga-Pizano
GCGraciela Libier Cabrera‐Rivera
Graciela Libier Cabrera‐Rivera
EBEdna Basilio‐Gálvez
Edna Basilio‐Gálvez
EFEduardo Ferat‐Osorio
Eduardo Ferat‐Osorio
The difficulty in predicting fatal outcomes in patients with coronavirus disease 2019 (COVID‐19) impacts the general morbidity and mortality due to severe acute respiratory syndrome‐coronavirus 2 infection, as it wears out the hospital services that care for these patients. Unfortunately, in several of the candidates for prognostic biomarkers proposed, the predictive power is compromised when patients have pre‐existing comorbidities. A cohort of 147 patients hospitalized for severe COVID‐19 was included in a descriptive, observational, single‐center, and prospective study. Patients were recruited during the first COVID‐19 pandemic wave (April–November 2020). Data were collected from the clinical history whereas immunophenotyping by multiparameter flow cytometry analysis allowed us to assess the expression of surface markers on peripheral leucocyte. Patients were grouped according to the outcome in survivors or non‐survivors. The prognostic value of leucocyte, cytokines or HLA‐DR, CD39, and CD73 was calculated. Hypertension and chronic renal failure but not obesity and diabetes were conditions more frequent among the deceased patient group. Mixed hypercytokinemia, including inflammatory (IL‐6) and anti‐inflammatory (IL‐10) cytokines, was more evident in deceased patients. In the deceased patient group, lymphopenia with a higher neutrophil‐lymphocyte ratio (NLR) value was present. HLA‐DR expression and the percentage of CD39+ cells were higher than non‐COVID‐19 patients but remained similar despite the outcome. Receiver operating characteristic analysis and cutoff value of NLR (69.6%, 9.4), percentage NLR (pNLR; 71.1%, 13.6), and IL‐6 (79.7%, 135.2 pg/mL). The expression of HLA‐DR, CD39, and CD73, as many serum cytokines (other than IL‐6) and chemokines levels do not show prognostic potential, were compared to NLR and pNLR values.

2 May 2022
Verified
Journal Article
Open access
SCSalvador Calleja-Alarcón
Salvador Calleja-Alarcón
LSLuis Alejandro Sánchez-Hurtado
Luis Alejandro Sánchez-Hurtado
LRLaura Romero-Gutiérrez
Laura Romero-Gutiérrez
JGJuan Carlos Guerrero-Escobar
Juan Carlos Guerrero-Escobar
JÁJuan Emmanuel Ávila-García
Juan Emmanuel Ávila-García
La ketamina es utilizada en anestesia intravenosa en el mantenimiento en la anestesia general. Su efecto cuenta con propiedades para prevenir la dificultad respiratoria asociada a broncoconstricción y la secreción de histamina asociada a crisis asmática. Estos efectos derivan de la acción directa en el músculo bronquial, así como de la potencialización de las catecolaminas, por lo que su uso muy controversial, ya que hasta el día de hoy no hay suficientes estudios que lo sustenten. Además, el efecto de la ketamina en el broncoespasmo debido a anafilaxia no está estudiado. El tratamiento de elección es la epinefrina y hay factores que están asociados en el éxito de esta. El objetivo fue presentar el caso de una paciente con antecedente de alergia a midazolam, que presentó broncoespasmo al estar en contacto con este y a la que se le administró tratamiento no convencional con resultados favorables. presentamos el caso de una mujer joven con antecedentes de alergias a medicamentos, específicamente a benzodiacepinas, la cual presentó broncoespasmo y caída de la saturación posteriores al contacto con midazolam intraocular mientras laboraba. Se propuso la utilización de ketamina posterior a adrenalina, betaagonista y anticolinérgicos inhalados, esteroide y antihistamínico. es necesario hacer estudios que demuestren la eficacia de la ketamina en este contexto en particular; en este caso, los resultados fueron positivos.

27 April 2023 in medRxiv
Verified
Preprint
Open access
PDF file
Ruth Madera-SandovalRuth Madera-Sandoval
Ruth Madera-Sandoval
ACArturo Cerbulo
Arturo Cerbulo
LALourdes Andrea Arriaga-Pizano
Lourdes Andrea Arriaga-Pizano
GCGraciela Libier Cabrera-Rivera
Graciela Libier Cabrera-Rivera
EBEdna Basilio-Gálvez
Edna Basilio-Gálvez
EFEduardo Ferat-Osorio
Eduardo Ferat-Osorio
Background The difficulty to predict fatal outcomes in COVID-19 patients, impacts in the general morbidity and mortality due to SARSCoV2 infection, as it wears out the hospital services that care for these patients. Unfortunately, in several of the candidates for prognostic biomarkers proposed, the predictive power is compromised when patients have pre-existing co-morbidities. Methods A cohort of one hundred and forty-seven patients hospitalized for severe COVID19 was included in a descriptive, observational, single-center, and prospective study. Patients were recruited during the first COVID-19 pandemic wave (April-Nov, 2020). Data were collected from the clinical history while immunophenotyping by multiparameter flow cytometry analysis allowed us to assess the expression of surface markers on peripheral leukocytes. Patients were grouped according to the outcome in survivor or decease. The prognostic value of leukocytes, cytokines or HLA-DR, CD39, and CD73 was calculated. Results Hypertension and chronic renal failure but not obesity and diabetes were conditions more frequent among the decease group. Mixed hypercitokinemia, including inflammatory (IL-6) and anti-inflammatory (IL-10) cytokines, was more evident in deceased patients. In the decease group, lymphopenia with a higher NLR value was present. HLA-DR expression and the percentage of CD39+ cells were higher than non COVID-19 patients, but remain similar despite outcome. ROC analysis and cut-off value of NLR (69.6%, 9.4), pNLR (71.1%, 13.6), IL-6 (79.7%, 135.2 pg/mL). Conclusion The expression of HLA-DR, CD39, and CD73, as many serum cytokines (other than IL-6) and chemokines levels do not show prognostic potential compared to NLR and pNLR values.

3 March 2026
Verified
Journal Article
Open access
JVJesús Alberto Valadez-Andrade
Jesús Alberto Valadez-Andrade
SCSalvador Calleja-Alarcón
Salvador Calleja-Alarcón
LSLuis Alejandro Sánchez-Hurtado
Luis Alejandro Sánchez-Hurtado
LRLaura Romero-Gutiérrez
Laura Romero-Gutiérrez
Mechanical ventilation is used in conjunction with sedation, which is titrated with clinical scales based on the therapeutic objective. It is difficult to find a reliable marker of respiratory drive in critically ill patients, so determining the correlation between the depth of sedation and airway occlusion pressure at 100 milliseconds (P0.1) would help titrate the depth of sedation and regulate respiratory drive. To determine whether P0.1 correlates with the depth of sedation measured with a clinical RASS scale and the bispectral index. A prospective cohort study was conducted with non-neurocritical patients undergoing mechanical ventilation from April 1, 2023, to September 30, 2023, in a tertiary care hospital in Mexico City. 229 patients were included. Pearson's correlation was applied comparing the simultaneously measured BIS with the P0.1, finding a correlation of 0.64 with a p < 0.001. The correlation of this with RASS was 0.43, with propofol -0.18, with benzodiazepines -0.036, with buprenorphine -0.25, and with dexmedetomidine 0.051. There was a stronger correlation of P0.1 with the BIS compared with the RASS and the doses of the drugs used. It could be used for titrating sedation in non-neurocritical patients.

2 January 2023
Verified
Journal Article
Open access
ALAura Angélica López-García
Aura Angélica López-García
MRMiguel Ángel Ramos-Choreño
Miguel Ángel Ramos-Choreño
LSLuis Alejandro Sánchez-Hurtado
Luis Alejandro Sánchez-Hurtado
LRLaura Romero-Gutiérrez
Laura Romero-Gutiérrez
SCSalvador Calleja-Alarcón
Salvador Calleja-Alarcón
TCTania Colín-Martínez
Tania Colín-Martínez
The COVID-19 disease has represented one of the most important threats to health. The most severe form is acute respiratory distress syndrome (ARDS). The inflammatory response can cause hematologic changes. To determine the association between the Neutrophil/lymphocyte ratio (NLR) and the mean platelet volume (MPV) associated with mortality in critically ill patients with COVID-19 and ARDS. A retrospective study was carried out in an intensive care unit (ICU) in a public hospital, with patients in critical condition due to COVID-19 and on mechanical ventilation. The clinical characteristics of admission and severity of the disease were recorded. The end point was the ICU discharge condition. 162 subjects were gathered, 103 were men, with a mean age of 54.54 ± 13.53 years. 66.7% died in the ICU. The NLR had an area under the curve (aROC) of 0.62, with a cut-off point for mortality of > 7.04, sensitivity of 94.4%, specificity of 29.63%. The VPM had an aROC of 0.65 with a cut-off point > 9.5, sensitivity of 30.84%, and specificity of 92.59%; finally, the APACHE II had an aROC of 0.67 with a cut-off point > 14, sensitivity of 51.4% and specificity of 80%. The NLR presented an odds ratio (OR) of 5.02, the VPM 2.06 and the APACHE II score 1.16. NLR, MPV, and APACHE II at ICU admission are associated with mortality for critically ill patients with COVID-19.

3 March 2026
Verified
Journal Article
Open access
SCSalvador Calleja-Alarcón
Salvador Calleja-Alarcón
LSLuis Alejandro Sánchez-Hurtado
Luis Alejandro Sánchez-Hurtado
LRLaura Romero-Gutiérrez
Laura Romero-Gutiérrez
SDSudán Jareth Diaz-Reyna
Sudán Jareth Diaz-Reyna
MAMarco Antonio Amador-González
Marco Antonio Amador-González
Approximately 30% of surgical procedures in the United States require orotracheal intubation. Generally laryngeal and tracheal injuries are rare. However, when they do occur, they can lead to major complications. Subcutaneous emphysema is the most common clinical presentation and is mostly treated conservatively and self-limiting. However, when it is Grade V, control strategies should be considered. There are reports in the literature on micro-drainage of subcutaneous emphysema through a fenestrated peripheral venous catheter with satisfactory results. We present the case of a 69-year-old diabetic man with hypertension and a history of pulmonary thromboembolism. He presented with a Grade II tracheal injury and Grade V subcutaneous emphysema. Micro-drainage of subcutaneous emphysema was performed through a size 14 peripheral venous catheter with fenestration, with adequate results. The peripheral venous catheter for microdrainage is a minimally invasive option for the treatment of grade V subcutaneous emphysema associated with tracheal injury. It can be a conservative strategy and, in some cases, can avoid the need for major interventions.